Summit Drug Development Services LLC, is a drug development services company located in Rockville, Maryland.  Summit is a wholly owned subsidiary of Cornucopia Pharmaceuticals Inc. a Delaware corporation that was founded in January of 2004.  Summit offers comprehensive drug development services to the biotechnology and pharmaceutical industry to advance new technologies from discovery to the marketplace. Our services span all areas of drug and biologics development including preclinical, manufacturing, regulatory and clinical development activities.  Summit’s goal is to understand your drug development needs and provide you with the level of assistance you require to accomplish your goals and meet project milestones. Summit can “fill in the gaps” you may have in your organization, by managing and conducting preclinical, manufacturing, regulatory and/or clinical aspects of your development program, thus becoming an extension of your project team.  Summit staff have extensive experience in drug development in the pharmaceutical, biotechnology and contract services industries as well as direct experience working within the Food and Drug Administration (FDA).  The staff have broad capabilities across technology and therapeutic areas ranging from natural products to small molecules to gene therapies. With this broad experience base, Summit can provide strategic support to your organization in the preparation of comprehensive development plans as well as the resources to implement these plans, thus “making them happen”.